Your browser doesn't support javascript.
loading
The European Code of Cancer Practice.
Lawler, Mark; Oliver, Kathy; Gijssels, Stefan; Aapro, Matti; Abolina, Agnese; Albreht, Tit; Erdem, Sema; Geissler, Jan; Jassem, Jacek; Karjalainen, Sakari; La Vecchia, Carlo; Lievens, Yolande; Meunier, Françoise; Morrissey, Mike; Naredi, Peter; Oberst, Simon; Poortmans, Philip; Price, Richard; Sullivan, Richard; Velikova, Galina; Vrdoljak, Eduard; Wilking, Nils; Yared, Wendy; Selby, Peter.
Affiliation
  • Lawler M; Faculty of Medicine, Health and Life Sciences, Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland, UK.
  • Oliver K; International Brain Tumour Alliance, Tadworth, Surrey, England, UK.
  • Gijssels S; Past Co-Chair of the Patient Advisory Committee, European Cancer Organisation, Belgium.
  • Aapro M; European Cancer Organisation, Brussels, Belgium.
  • Abolina A; European Cancer Organisation, Brussels, Belgium.
  • Albreht T; National Institute of Public Health, Slovenia.
  • Erdem S; European Cancer Organisation Patient Advisory Committee (ECCO PAC), Europa Donna, Milan, Italy.
  • Geissler J; CML Advocates Network, Leukaemie-Online / LeukaNET, Germany.
  • Jassem J; Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland.
  • Karjalainen S; Cancer Society of Finland and Cancer Foundation Finland, Tampere University, Finland.
  • La Vecchia C; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy.
  • Lievens Y; Radiation Oncology Department, Ghent University Hospital & Ghent University, Ghent, Belgium.
  • Meunier F; Federation of European Academies of Medicine, Brussels, Belgium.
  • Morrissey M; European Cancer Organisation, Brussels, Belgium.
  • Naredi P; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Oberst S; Organisation of European Cancer Institutes, Brussels, Belgium.
  • Poortmans P; Department of Radiation Oncology, Iridium Netwerk and University of Antwerp, Belgium.
  • Price R; European Cancer Organisation, Brussels, Belgium.
  • Sullivan R; Institute of Cancer Policy, Conflict & Health Research Group, King's College London, King's Health Partners Comprehensive Cancer Centre, London, England, UK.
  • Velikova G; Leeds Institute of Medical Research, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, England, UK.
  • Vrdoljak E; Center for Oncology, Professor at the Faculty of Medicine at the University of Split, Croatia.
  • Wilking N; Department of Oncology and Radiation Physics, Skane University Hospital, Lund, Malmo, Sweden.
  • Yared W; Association of European Cancer Leagues, Brussels, Belgium.
  • Selby P; Leeds Institute of Medical Research, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, England, UK; University of Lincoln, England, UK. Electronic address: p.j.selby@leeds.ac.uk.
J Cancer Policy ; 28: 100282, 2021 06.
Article in En | MEDLINE | ID: mdl-35559911
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hospice and Palliative Care Nursing / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Cancer Policy Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hospice and Palliative Care Nursing / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Cancer Policy Year: 2021 Type: Article Affiliation country: United kingdom